![Neurology Today in 5 artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts123/v4/41/85/4d/41854dd0-c829-ce75-cd54-f1011436bfb9/mza_2998942219566680569.png/100x100bb.jpg)
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today in 5
English - April 18, 2024 03:00 - 4 minutes - 6.2 MB - ★★★★★ - 14 ratingsScience Health & Fitness Medicine neurology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.